Two novel Salmonella genomic island 1 variants in Proteus mirabilis isolates from swine farms in China.

Detection of SGI1/PGI1 Elements and Resistance to Extended-Spectrum Cephalosporins in Proteae of Animal Origin in France. Front Microbiol (2017) 0.78

Multidrug Resistance Salmonella Genomic Island 1 in a Morganella morganii subsp. morganii Human Clinical Isolate from France. mSphere (2017) 0.75

Complete nucleotide sequence of a 43-kilobase genomic island associated with the multidrug resistance region of Salmonella enterica serovar Typhimurium DT104 and its identification in phage type DT120 and serovar Agona. J Bacteriol (2001) 4.83

Complete nucleotide sequences of plasmids pEK204, pEK499, and pEK516, encoding CTX-M enzymes in three major Escherichia coli lineages from the United Kingdom, all belonging to the international O25:H4-ST131 clone. Antimicrob Agents Chemother (2009) 2.75

Epidemic salmonella typhimurium DT 104--a truly international multiresistant clone. J Antimicrob Chemother (2000) 2.47

The Salmonella genomic island 1 is an integrative mobilizable element. Mol Microbiol (2005) 2.29

The genomic island SGI1, containing the multiple antibiotic resistance region of Salmonella enterica serovar Typhimurium DT104 or variants of it, is widely distributed in other S. enterica serovars. J Bacteriol (2005) 2.26

Proteus mirabilis clinical isolate harbouring a new variant of Salmonella genomic island 1 containing the multiple antibiotic resistance region. J Antimicrob Chemother (2006) 1.88

Novel insertion sequence- and transposon-mediated genetic rearrangements in genomic island SGI1 of Salmonella enterica serovar Kentucky. Antimicrob Agents Chemother (2008) 1.45

Association of IS26-composite transposons and complex In4-type integrons generates novel multidrug resistance loci in Salmonella genomic island 1. J Antimicrob Chemother (2008) 1.42

The Salmonella genomic island 1 is specifically mobilized in trans by the IncA/C multidrug resistance plasmid family. PLoS One (2010) 1.25

Salmonella genomic island 1 (SGI1), variant SGI1-I, and new variant SGI1-O in proteus mirabilis clinical and food isolates from China. Antimicrob Agents Chemother (2007) 1.20

Salmonella genomic islands and antibiotic resistance in Salmonella enterica. Future Microbiol (2010) 1.16

The new variant of Salmonella genomic island 1 (SGI1-V) from a Proteus mirabilis French clinical isolate harbours blaVEB-6 and qnrA1 in the multiple antibiotic resistance region. J Antimicrob Chemother (2011) 1.02

High prevalence of extended-spectrum-cephalosporin-resistant enterobacteriaceae in poultry meat in Switzerland: emergence of CMY-2- and VEB-6-possessing Proteus mirabilis. Antimicrob Agents Chemother (2013) 0.99

Emergence of Salmonella genomic island 1 (SGI1) among Proteus mirabilis clinical isolates in Dijon, France. J Antimicrob Chemother (2013) 0.94

New variant Salmonella genomic island 1-U in Proteus mirabilis clinical and food isolates from South China. J Antimicrob Chemother (2011) 0.94

Stability, entrapment and variant formation of Salmonella genomic island 1. PLoS One (2012) 0.92

Emergence and evolution of multiply antibiotic-resistant Salmonella enterica serovar Paratyphi B D-tartrate-utilizing strains containing SGI1. Antimicrob Agents Chemother (2009) 0.89

Molecular characteristics of Salmonella genomic island 1 in Proteus mirabilis isolates from poultry farms in China. Antimicrob Agents Chemother (2014) 0.89

The complete sequence of Salmonella genomic island SGI1-K. J Antimicrob Chemother (2014) 0.81

The complete sequence of Salmonella genomic island SGI2. J Antimicrob Chemother (2014) 0.80